Abeona Therapeutics
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $11,380 | $8,720 | $5,420 | $0 |
Gross Profit | 7,203 | 5,155 | 2,583 | -488 |
EBITDA | -18,795 | -15,374 | -18,699 | -18,569 |
EBIT | -19,495 | -16,243 | -19,791 | -19,457 |
Net Income | -20,191 | -17,075 | -20,460 | -5,161 |
Net Change In Cash | 11,380 | 8,720 | 5,420 | 0 |
Free Cash Flow | -17,975 | -20,739 | -19,106 | -23,707 |
Cash | 56,229 | 61,374 | 78,437 | 83,222 |
Basic Shares | 57,048 | 56,620 | 66,135 | 54,242 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $5,820 | $0 | $3,500 | $1,414 |
Gross Profit | 4,288 | -2,907 | 1,895 | 964 |
EBITDA | 78,586 | -56,619 | -50,572 | -34,383 |
EBIT | 75,023 | -59,526 | -53,770 | -38,960 |
Net Income | 71,183 | -63,734 | -54,188 | -39,696 |
Net Change In Cash | 5,820 | 0 | 3,500 | 1,414 |
Free Cash Flow | -84,301 | -58,461 | -37,340 | -43,613 |
Cash | 78,437 | 23,357 | 14,473 | 14,217 |
Basic Shares | 66,135 | 41,048 | 21,380 | 7,862 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.35 |
2026-03-31 | -$0.30 |
2025-12-31 | -$0.36 |
2025-09-30 | -$0.11 |